“
EyePoint, Inc.
Also ReadManojNair · March 4, 2026
EyePoint, Inc. (NASDAQ: EYPT), which is engaged in the development of therapeutics for retinal diseases, on Wednesday announced financial results for the fourth quarter of fiscal 2025, reporting lower revenues and a wider net loss.
Source link
#Earnings #Summary #EyePoint #EYPT #net #loss #widens #AlphaStreet #News
